Clearmind Medicine Inc. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
Clearmind Medicine Inc. (CMND) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 24.02 thousand CAD/shares as of 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2026-03-12
- 2026-01-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 24.02K CAD/shares.
- 2025-10-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 24.02K CAD/shares.
- 2025-07-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 601.70 CAD/shares.
- 2025-04-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 601.70 CAD/shares.
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2026-01-31 | 24.02K CAD/shares 6-K · filed 2026-03-12 | |
| 2025-10-31 | 24.02K CAD/shares 6-K · filed 2026-03-12 | |
| 2025-07-31 | 601.70 CAD/shares 6-K · filed 2025-09-11 | |
| 2025-04-30 | 601.70 CAD/shares 6-K · filed 2025-06-12 | |
| 2025-01-31 | 601.72 CAD/shares 6-K · filed 2025-03-13 | |
| 2024-10-31 | 24.07K CAD/shares 6-K · filed 2026-03-12 | 601.71 CAD/shares 20-F · filed 2025-01-22 |
| 2024-07-31 | 601.70 CAD/shares 6-K · filed 2024-09-16 | |
| 2024-04-30 | 601.70 CAD/shares 6-K · filed 2024-06-13 | |
| 2024-01-31 | 601.70 CAD/shares 6-K · filed 2024-03-19 | |
| 2023-10-31 | 24.12K CAD/shares 20-F · filed 2026-01-20 | 603.12 CAD/shares 6-K · filed 2024-03-19 |
| 2022-10-31 | 613.50 CAD/shares 20-F · filed 2025-01-22 | 8.30 CAD/shares 20-F · filed 2023-02-06 |
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2026-01-31 | $17711.94 6-K · filed 2026-03-12 | |
| 2025-10-31 | $17136.00 6-K · filed 2026-03-12 | |
| 2025-07-31 | $434.63 6-K · filed 2025-09-11 | |
| 2025-04-30 | $435.64 6-K · filed 2025-06-12 | |
| 2025-01-31 | $415.44 6-K · filed 2025-03-13 | |
| 2024-10-31 | $17295.38 6-K · filed 2026-03-12 | $432.38 20-F · filed 2025-01-22 |
| 2024-07-31 | $435.73 6-K · filed 2024-09-16 | |
| 2024-04-30 | $437.73 6-K · filed 2024-06-13 | |
| 2024-01-31 | $449.13 6-K · filed 2024-03-19 | |
| 2023-10-31 | $17392.80 20-F · filed 2026-01-20 | $434.81 6-K · filed 2024-03-19 |
| 2022-10-31 | $450.64 20-F · filed 2025-01-22 |